Organon & Co. OGN
The next Organon & Co. dividend is expected to go ex in 2 months and to be paid in 2 months.
The previous Organon & Co. dividend was 28c and it went ex 2 months ago and it was paid 15 days ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 2.0.
|Summary||Previous dividend||Next dividend|
|Per share||28c||Sign Up Required|
|Declaration date||04 Aug 2022 (Thu)||11 Nov 2022 (Fri)|
|Ex-div date||12 Aug 2022 (Fri)||18 Nov 2022 (Fri)|
|Pay date||15 Sep 2022 (Thu)||12 Dec 2022 (Mon)|
Enter the number of Organon & Co. shares you hold and we'll calculate your dividend payments:
Sign up for Organon & Co. and we'll email you the dividend information when they declare.
Add Organon & Co. to receive free notifications when they declare their dividends.
Your account is set up to receive Organon & Co. notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Quarterly||06 May 2027||12 May 2027||07 Jun 2027||USD||Sign up||—|
|Forecast||Quarterly||08 Feb 2027||15 Feb 2027||05 Mar 2027||USD||Sign up||—|
|Forecast||Quarterly||09 Nov 2026||13 Nov 2026||07 Dec 2026||USD||Sign up||—|
|Forecast||Quarterly||30 Jul 2026||07 Aug 2026||10 Sep 2026||USD||Sign up||—|
|Forecast||Quarterly||07 May 2026||13 May 2026||08 Jun 2026||USD||Sign up||—|
|Forecast||Quarterly||09 Feb 2026||16 Feb 2026||06 Mar 2026||USD||Sign up||—|
|Forecast||Quarterly||10 Nov 2025||14 Nov 2025||08 Dec 2025||USD||Sign up||—|
|Forecast||Quarterly||31 Jul 2025||08 Aug 2025||11 Sep 2025||USD||Sign up||—|
|Forecast||Quarterly||08 May 2025||14 May 2025||09 Jun 2025||USD||Sign up||—|
|Forecast||Quarterly||10 Feb 2025||17 Feb 2025||07 Mar 2025||USD||Sign up||—|
|Forecast||Quarterly||11 Nov 2024||15 Nov 2024||09 Dec 2024||USD||Sign up||—|
|Forecast||Quarterly||01 Aug 2024||09 Aug 2024||12 Sep 2024||USD||Sign up||—|
|Forecast||Quarterly||09 May 2024||15 May 2024||10 Jun 2024||USD||Sign up||—|
|Forecast||Quarterly||12 Feb 2024||19 Feb 2024||08 Mar 2024||USD||Sign up||—|
|Forecast||Quarterly||13 Nov 2023||17 Nov 2023||11 Dec 2023||USD||Sign up||—|
|Forecast||Quarterly||03 Aug 2023||11 Aug 2023||14 Sep 2023||USD||Sign up||—|
|Forecast||Quarterly||11 May 2023||17 May 2023||12 Jun 2023||USD||Sign up||—|
|Forecast||Quarterly||13 Feb 2023||17 Feb 2023||10 Mar 2023||USD||Sign up||—|
|Forecast||Quarterly||11 Nov 2022||18 Nov 2022||12 Dec 2022||USD||Sign up||—|
|Paid||Quarterly||04 Aug 2022||12 Aug 2022||15 Sep 2022||USD||28c||28c||😄|
|Paid||Quarterly||05 May 2022||13 May 2022||16 Jun 2022||USD||28c||28c||😄|
|Paid||Quarterly||17 Feb 2022||25 Feb 2022||17 Mar 2022||USD||28c||28c||😄|
|Paid||Quarterly||11 Nov 2021||19 Nov 2021||16 Dec 2021||USD||28c||28c||😄|
|Paid||Quarterly||12 Aug 2021||20 Aug 2021||13 Sep 2021||USD||—||28c|
|2022||Sign Up Required|
|2023||Sign Up Required|
|2024||Sign Up Required|
|2025||Sign Up Required|
|2026||Sign Up Required|
Organon & Co. Optimized Dividend Chart
About Organon & Co.
Organon & Co. is a science-based global pharmaceutical company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. Its women's health portfolio includes Nexplanon or Implanon NXT, which is a patented long-acting reversible contraceptive. Its operating segments include the Organon Products segment. The Organon Products segment is engaged in developing and delivering health solutions through its portfolio of prescription therapies within women’s health, biosimilars, and established brands. The Company's products segment portfolio includes: Women’s Health, Biosimilars and Established Brands. Women’s Health contains contraception and fertility brands, such as Nexplanon or Implanon NXT, NuvaRing and elonva. The Company's Biosimilars portfolio consists of three immunology products: Brenzys, Renflexis and Hadlima; and two oncology products: Ontruzant and Aybintio.
- Pharmaceuticals & Biotechnology
- United States
- Share Price
- $23.55 (yesterday's closing price)
- Shares in Issue
- 254 million
- Market Cap
- Market Indices
- S&P 500